tomwang ©

General Dynamics “was awarded the U.S. Army Medical Materiel Development Activity (USAMMDA) Strategic Support Services contract to provide support services for vaccine, drug and medical device research and development programs. The single-award, task order contract has a potential value of approximately $52 million for five years.

General Dynamics will provide programmatic, scientific, technical, logistical and administrative support for development requirements of medical products at the USAMMDA. Additionally, the company will help guide medical technologies through the U.S. Food and Drug Administration regulatory process and develop plans to bring the products into service….” Source: General Dynamics: Read The Full Press Release Here.



Please enter your comment!
Please enter your name here